Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  New England Journal of Medicine

• Publication date

  1992-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199211123272002PMID 1406859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral anticoagulant drugs.

  1992cited by this paper
• Stroke Prevention in Atrial Fibrillation Study: Final Results

  1991cited by this paper
• Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

  1991cited by this paper
• The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.

  1990cited by this paper
• Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators.

  1990cited by this paper
• Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.

  1990cited by this paper
• Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

  1989cited by this paper
• Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement.

  1988cited by this paper
• The natural history of lone atrial fibrillation. A population-based study over three decades.

  1987cited by this paper
• Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study.

  1985cited by this paper
• BMDP statistical software

  1983cited by this paper
• Epidemiologic features of chronic atrial fibrillation: the Framingham study.

  1982cited by this paper
• Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

  1982cited by this paper
• Epidemiologic assessment of chronic atrial fibrillation and risk of stroke

  1978cited by this paper
• Longitudinal survey of ischaemic heart disease in randomly selected sample of older population.

  1977cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

  1976cited by this paper
• Electrocardiographic Findings in 122,043 Individuals

  1962cited by this paper

• Gastrointestinal Hemorrhage in Patients Receiving Antithrombotic Therapy: Clinical Patterns and Prognosis from Two Tertiary Care Hospitals

  2025cites this paper
• Association between first anticoagulant prescription and embolic and hemorrhagic events among older adults with atrial fibrillation

  2025cites this paper
• A mini review on the regulation of coagulation homeostasis through interfering with vitamin K-dependent coagulation/anticoagulation factors.

  2025cites this paper
• A new score for predicting intracranial hemorrhage in patients using anticoagulant drugs

  2025cites this paper
• Left atrial appendage occlusion in patients with atrial fibrillation and previous Intracranial Hemorrhage or Cerebral Amyloid Angiopathy: A systematic review and meta-analysis

  2025cites this paper
• Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework.

  2025cites this paper
• Systemic Embolism and Clinically Significant Bleeding Events in Older Adults with Nonvalvular Atrial Fibrillation After Treatment with Direct Oral Anticoagulants and Warfarin: A Retrospective Cohort Study in Japan

  2024cites this paper
• Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials

  2024cites this paper
• Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study

  2024cites this paper
• Protocol for a randomised controlled trial comparing warfarin with no oral anticoagulation in patients with atrial fibrillation on chronic dialysis: the Danish Warfarin-Dialysis (DANWARD) trial

  2024cites this paper
• Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies

  2024cites this paper
• Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit

  2024cites this paper
• The ATHERO-AF Study

  2024cites this paper
• Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.

  2024cites this paper
• Support for Thrombolytic Therapy for Acute Stroke Patients on Direct Oral Anticoagulants: Mortality and Bleeding Complications

  2024cites this paper
• Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines

  2023cites this paper
• Long Term Outcomes and Anticoagulation in Mitral Valve Surgery - A Report from the Society of Thoracic Surgeons Database.

  2023cites this paper
• Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan

  2023cites this paper
• Re-bleeding and all-cause mortality risk in non-variceal upper gastrointestinal bleeding: focusing on patients receiving oral anticoagulant therapy

  2023cites this paper
• Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA2DS2-VASc Score 1: A Nationwide Study

  2023cites this paper
• Evaluation of Quantitative Decision‐Making for Rhythm Management of Atrial Fibrillation Using Tabular Q‐Learning

  2023cites this paper
• Position Statement on In-hospital/Clinic Point-of-care Coagulation Testing for Anticoagulation Monitoring in Saudi Arabia

  2023cites this paper
• Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study

  2023cites this paper
• Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review.

  2023cites this paper
• Focal Anticoagulation by Somatic Gene Transfer: Towards Preventing Cardioembolic Stroke.

  2023cites this paper
• Overestimation of anticoagulant benefit in patients with atrial fibrillation and low life expectancy: evidence from 12 randomized trials

  2023cites this paper
• Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease

  2022cites this paper
• Head-to-head Efficacy and Safety of Rivaroxaban, Apixaban and Dabigatran in an Observational Nationwide Targeted Trial.

  2022cites this paper
• Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations.

  2022cites this paper
• Atrial Fibrillation and Hypertension: "Quo Vadis".

  2022cites this paper
• Evaluation and Interventional Management of Cardiac Dysrhythmias.

  2022cites this paper
• Screening for Atrial Fibrillation: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2022cites this paper
• Mechanical versus bioprosthetic valves in chronic dialysis: a systematic review and meta-analysis

  2022cites this paper
• Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people

  2022cites this paper
• Suprachoroidal Hemorrhage after XEN Gel Implant Requiring Surgical Drainage

  2022cites this paper
• Impact of treatment adherence on the effectiveness and safety of oral anticoagulants in patients with atrial fibrillation: A retrospective cohort study.

  2022cites this paper
• Left Atrial Appendage Occlusion: Current Stroke Prevention Strategies and a Shift Toward Data-Driven, Patient-Specific Approaches

  2022cites this paper
• In Search of the Optimal Antithrombotic Regimen for Intracerebral Hemorrhage Survivors with Atrial Fibrillation

  2022cites this paper
• Use of anticoagulant drugs in patients with atrial fibrillation. Does adherence to therapy have a prognostic impact?

  2022cites this paper
• Clinical and health economic evaluation of a post-stroke arrhythmia monitoring service.

  2022cites this paper
• The Impact of Landscape Changes on Data and Safety Monitoring Board Oversight of Clinical Trials.

  2022cites this paper
• Potential clinical applications of phytopharmaceuticals for the in‐patient management of coagulopathies in COVID‐19

  2022cites this paper
• Anticoagulation for Atrial Fibrillation: A Review of Current Literature and Views.

  2022cites this paper
• Antithrombotic Therapy in the Prevention of Stroke

  2021cites this paper
• Comparative risk for intracranial hemorrhage related to new oral anticoagulants

  2021cites this paper
• Atrial Fibrillation and Ischemic Stroke: A Clinical Review

  2021cites this paper
• Role and Timing of Aspirin Therapy Following PCI in Patients With Atrial Fibrillation.

  2021cites this paper
• Warfarin: time in therapeutic range, a single centre study on patients using warfarin for stroke prevention in non-valvular atrial fibrillation and prosthetic heart valves

  2021cites this paper
• Benefit and harm of anticoagulation in the prevention of thromboembolic stroke for non‐valvular atrial fibrillation in haemodialysis patients: a Top End of Northern Australia study

  2021cites this paper
• Pharmacogenetics of Direct Oral Anticoagulants

  2021cites this paper
• CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillation

  2021cites this paper
• Antithrombotic Therapy for Stroke Patients with Cardiovascular Disease

  2021cites this paper
• Left atrial appendage occlusion in patients with atrial fibrillation: focus on current evidence and commercially available devices

  2021cites this paper
• Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms

  2021cites this paper
• Machine Learning Methodologies for Prediction of Rhythm-Control Strategy in Patients Diagnosed With Atrial Fibrillation: Observational, Retrospective, Case-Control Study

  2021cites this paper
• Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System

  2021cites this paper
• Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies

  2021cites this paper
• Comparison of Low-Dose Direct Acting Anticoagulant and Warfarin in patients Aged ≥80 years With Atrial Fibrillation.

  2021cites this paper
• Atrial fibrillation and flutter – the state of the art. Part 2

  2021cites this paper
• Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure

  2021cites this paper
• Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions

  2021cites this paper
• The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years

  2020cites this paper
• Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke.

  2020cites this paper
• Safety and efficacy of prothrombin complex concentrate (PCC) for anticoagulation reversal in patients undergoing urgent neurosurgical procedures: a systematic review and metaanalysis

  2020cites this paper
• Atrial Fibrillation and Atrial Flutter

  2020cites this paper
• Assessment of Shared Decision-making for Stroke Prevention in Patients With Atrial Fibrillation

  2020cites this paper
• Warfarin therapy in atrial fibrillation: assessment of patient knowledge of risks and benefits

  2020cites this paper
• Clinical Outcomes of AF Patients with Non-Rheumatic Valvular Heart Disease in Thailand

  2020cites this paper
• Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation

  2020cites this paper
• Left atrial appendage occlusion for ischemic stroke prevention in patients with non-valvular atrial fibrillation: clinical expert opinion and consensus statement for the Asian-Pacific region

  2020cites this paper
• Association Between the Prothrombin Time–International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of Bacteroides fragilis to Antibiotics

  2020cites this paper
• Antithrombotic treatment after atrial fibrillation ablation.

  2020cites this paper
• Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017

  2020cites this paper
• Antithrombotic therapy in patients with recent stroke and atrial fibrillation.

  2020cites this paper
• Prevalence of atrial fibrillation, oral anticoagulation prescription and associated factors in Brazilian older adults

  2020cites this paper
• Assessment of a Machine Learning Model Applied to Harmonized Electronic Health Record Data for the Prediction of Incident Atrial Fibrillation

  2020cites this paper
• Reversal Of Warfarin-Associated Coagulopathy: Prothrombin Complex Concentrates Versus Fresh Frozen Plasma In Elderly Patients Presenting With Intracranial Hemorrhage

  2020cites this paper
• Pharmacologic Management of Atrial Fibrillation and Flutter

  2020cites this paper
• Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation

  2020cites this paper
• [Atrial fibrillation].

  2019cites this paper
• Cerebrovascular disease in the elderly patient

  2019cites this paper
• Atrial Fibrillation Detection in ICU Patients: A Pilot Study on MIMIC III Data*

  2019cites this paper
• Impact of Anticoagulation Intensity in Korean Patients with Atrial Fibrillation: Is It Different from Western Population?

  2019cites this paper
• Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019

  2019cites this paper
• Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease

  2019cites this paper
• Knowledge, Adherence, and Quality of Life among Warfarin Therapy Users

  2019cites this paper
• Oral anticoagulant monitoring: Are we on the right track?

  2019cites this paper
• Characterization of Decellularized Human Pericardium for Tissue Engineering and Regenerative Medicine Applications

  2019cites this paper
• Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data

  2019cites this paper
• Anticoagulation Patterns in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention in an Academic Center

  2019cites this paper
• Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline

  2019cites this paper
• Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation.

  2019cites this paper
• Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation

  2019cites this paper
• Imágenes cardiovasculares en la valoración del paciente candidato para el cierre percutáneo de la orejuela izquierda

  2019cites this paper
• Left atrial appendage strain rate is associated with documented thromboembolism in nonvalvular atrial fibrillation

  2019cites this paper
• Paroxysmal Atrial Fibrillation

  2019cites this paper
• The New Oral Anticoagulants and Anesthesia

  2019cites this paper
• Development of a Prediction Model for Incident Atrial Fibrillation using Machine Learning Applied to Harmonized Electronic Health Record Data

  2019cites this paper
• Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users

  2019cites this paper
• New‐onset postoperative atrial fibrillation after heart surgery

  2019cites this paper